← Open Payments lookup

DAVID GAMBLE: Open Payments

NPI 1033423249 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$169,516 in 433 payments from 17 companies in 2025. Trend: 2023 $166,511 · 2024 $193,820 · 2025 $169,516

Speaker / faculty: $129,861Travel & lodging: $29,375Food & beverage: $5,399Speaker / faculty: $4,881
CompanyPaymentsAmount
Corcept Therapeutics128$82,008
Lilly USA, LLC257$74,387
Novo Nordisk Inc8$6,146
Abbott Laboratories16$5,137
ABBVIE INC.4$1,426
Amgen Inc.5$104
Bayer Healthcare Pharmaceuticals Inc.3$78
Xeris Pharmaceuticals, Inc.3$66
Boehringer Ingelheim Pharmaceuticals, Inc.1$23
Novartis Pharmaceuticals Corporation1$21

Products named: Korlym, Ozempic, FREESTYLE LIBRE 3, MOUNJARO, SYNTHROID, Kerendia, REPATHA, RECORLEV.

Industry payments across UT — which companies pay providers there.